RESEARCHER PROFILE (Filmed May 2024)
Associate Professor Brett Gordon, AEP
Associate Professor of Exercise Physiology
Head, Department of Rural Clinical Sciences
La Trobe Rural Health School
La Trobe University,
Victoria, Australia
Dr Brett Gordon is Associate Professor of Exercise Physiology and Head, Department of Rural Clinical Sciences in the La Trobe Rural Health School. Brett is an experienced accredited exercise physiologist, academic and researcher, and has been recognised with the award of Senior Fellowship with the Higher Education Academy.
Associate Professor Gordon’s research is aimed at determining the optimal methods of prescribing and implementing exercise as part of the health care plan for people with cardiovascular disease and diabetes. Specifically, he is leading work to determine if and how the components of exercise can be considered as a whole for prescribing exercise to generate health benefits. This is important to overcome the series of barriers that people living in rural and regional areas experience when trying to become active.
Assoc Professor Gordon is highly regarded and regularly invited to contribute to national and international forums for his research, teaching, and leadership activities. He currently serves on the Exercise and Sports Science Australia Research Committee and is a member of the editorial board for Scientific Reports.
Source: Supplied
* AEP is the acronym for Accredited Exercise Physiologist
-
Healthier Food Retail
Professor Anna Peeters AM is a globally recognised public health leader whose career has spanned academia, policy and health system reform, with a strong focus on prevention and health equity. She is the CEO of VicHealth, bringing decades of experience in epidemiology, population health and evidence-based health promotion.
-
Targeting chemotherapy resistance in ovarian cancer patients
Dr Alex Cole, from the Centenary Institute’s Centre for Biomedical AI, is now leading the research focused on developing a new treatment to counteract a protein called follistatin (FST), known for making ovarian cancer cells resistant to chemotherapy.
By employing cutting-edge molecular biology and directed evolution techniques, the project aims to create nanobodies—small, precise molecules—that can block FST. If successful, these nanobodies could enhance the effectiveness of chemotherapy and improve ovarian cancer treatment rates.
-
Good and bad extracellular vesicles in health and disease
Associate Professor Joy Wolfram has joint appointments in the School of Chemical Engineering and the Australian Institute for Bioengineering and Nanotechnology at The University of Queensland, and through her work at the AIBN, she aims to develop a new paradigm of therapeutics (using nanotechnology and cell products) to treat life-threatening diseases that are major causes of death globally, including cardiovascular disease, kidney disease, and breast cancer.
